BGLAP and osteoporosis: Taken together, these results demonstrate that systemic delivery of amiR-ctsk by the bone-tropic capsid can counteract bone loss and enhance clinically relevant mechanical properties of bone after the onset of estrogen deficiency-induced osteoporosis by simultaneously suppressing OC-mediated bone resorption and promoting osteoblast-mediated bone formation.